VALACICLOVIR SANDOZ (Sandoz Pty Ltd)
Product name
VALACICLOVIR SANDOZ
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
44 working days (45)
Active ingredients
valaciclovir hydrochloride
Registration type
EOI
Indication
Generic medicine
VALACICLOVIR SANDOZ (film-coated tablets) is now also indicated for:- Treatment of recurrent herpes labialis (cold sores)
- Prevention of recurrent genital herpes
- Reduction of transmission of genital herpes in patients suffering from recurrent genital herpes. In addition to therapy with valaciclovir, it is recommended that patients use safer sex practices (see Section 4.4 Special warnings and precautions for use)